Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two Indian Drug Makers Make Acquisition Moves Abroad

This article was originally published in PharmAsia News

Executive Summary

Two more Indian drug makers have moved to buy at least part of foreign firms as the industry continues acquiring other assets. Dr. Reddy's Laboratories said it would buy the U.S. pharmaceutical contract manufacturing business of BASF, but did not disclose what it would be paying. Strides Arcolab said it would buy a larger stake in Genepharm Australasia, enough to give it 55 percent ownership of the Australian firm. In return for its equity stake, Strides said it would sell Genepharm its other Australian and Asian interests for $57.3 million. (Click here for more
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC068415

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel